FDA E2B(2) 2.2 DTD Combination Product Best Practices Document Release 18.104.22.168
(Doc ID 2537782.1)
Last updated on DECEMBER 19, 2019
Applies to:Oracle Argus Safety
Oracle Argus Interchange
Generic (Platform Independent)
Oracle Argus Safety
FDA E2B(2) 2.2 DTD Best Practices Document
Oracle Argus Safety 22.214.171.124 provides solution for the Post Marketing Safety Reporting (PMSR) of combination products that have received FDA marketing authorization.
While the FDA’s Combination Product reporting guidelines is in draft, Oracle plans to release the solution for Combination Product Reporting in phases.
Oracle Argus Safety 126.96.36.199 patch is the first phase of the solution that comprises of FDA E2B DTD 2.2 profile and the corresponding back-end table to store the PMOA and Constituent Product relation at Case level.
After the final guidelines are published by FDA, Oracle plans to release complete solution for Combination Product Reporting that comprises of UI changes to Console and Case Form along with FDA E2B DTD 2.2 profile and the back-end table.
When the complete solution is available, all the customers using 188.8.131.52 patch need to uptake the this release for Combination Product reporting and Argus Safety 184.108.40.206 patch would be made obsolete.
This document provides information on how to perform ICSR reporting to the FDA using the FDA E2B(R2) 2.2 DTD profile instead of the E2B(R2) 2.1 DTD profile, as well as special considerations about FDA E2B(R2) 2.2 report that is provided in this release.
The document contains the following sections:
- Section 1, "Configuration"
- Section 2, "Case Processing Considerations"
- Section 3, "Documentation Accessibility"
To view full details, sign in with your My Oracle Support account.
Don't have a My Oracle Support account? Click to get started!
In this Document